CA2864676C - Methods and kits for reducing non-specific nucleic acid amplification - Google Patents
Methods and kits for reducing non-specific nucleic acid amplification Download PDFInfo
- Publication number
- CA2864676C CA2864676C CA2864676A CA2864676A CA2864676C CA 2864676 C CA2864676 C CA 2864676C CA 2864676 A CA2864676 A CA 2864676A CA 2864676 A CA2864676 A CA 2864676A CA 2864676 C CA2864676 C CA 2864676C
- Authority
- CA
- Canada
- Prior art keywords
- nucleic acid
- methods
- kits
- acid amplification
- specific nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/113—Modifications characterised by incorporating modified backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/179—Modifications characterised by incorporating arbitrary or random nucleotide sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/204—Modifications characterised by specific length of the oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/107—Temperature of melting, i.e. Tm
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261599119P | 2012-02-15 | 2012-02-15 | |
| US61/599,119 | 2012-02-15 | ||
| US13/446,474 US9353393B2 (en) | 2012-02-15 | 2012-04-13 | Methods and kits for reducing non-specific nucleic acid amplification |
| US13/446,474 | 2012-04-13 | ||
| PCT/US2013/026136 WO2013123187A1 (en) | 2012-02-15 | 2013-02-14 | Methods and kits for reducing non-specific nucleic acid amplification |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2864676A1 CA2864676A1 (en) | 2013-08-22 |
| CA2864676C true CA2864676C (en) | 2021-06-15 |
Family
ID=48945882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2864676A Active CA2864676C (en) | 2012-02-15 | 2013-02-14 | Methods and kits for reducing non-specific nucleic acid amplification |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9353393B2 (2) |
| EP (1) | EP2814976B1 (2) |
| JP (1) | JP6225123B2 (2) |
| CN (1) | CN104093850B (2) |
| CA (1) | CA2864676C (2) |
| WO (1) | WO2013123187A1 (2) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10870099B2 (en) | 2012-07-26 | 2020-12-22 | Illumina, Inc. | Compositions and methods for the amplification of nucleic acids |
| US9938568B2 (en) | 2013-07-26 | 2018-04-10 | General Electric Company | Ligase-assisted nucleic acid circularization and amplification |
| US9587263B2 (en) | 2014-03-26 | 2017-03-07 | General Electric Company | Isothermal amplification under low salt condition |
| US10683534B2 (en) * | 2015-01-27 | 2020-06-16 | BioSpyder Technologies, Inc. | Ligation assays in liquid phase |
| US11987836B2 (en) | 2014-09-30 | 2024-05-21 | Global Life Sciences Solutions Usa Llc | Method for nucleic acid analysis directly from an unpurified biological sample |
| ES2818569T3 (es) | 2015-09-09 | 2021-04-13 | Drawbridge Health Inc | Métodos para la recopilación, estabilización y conservación de muestras |
| US10077459B2 (en) * | 2016-05-04 | 2018-09-18 | General Electric Company | Cell-free protein expression using rolling circle amplification product |
| WO2018209092A1 (en) * | 2017-05-10 | 2018-11-15 | Board Of Regents, The University Of Texas System | Methods and devices related to amplifying nucleic acid at a variety of temperatures |
| US11001868B2 (en) * | 2017-08-11 | 2021-05-11 | Global Life Sciences Solutions Operations UK Ltd | Cell-free protein expression using double-stranded concatameric DNA |
| CN111334562A (zh) * | 2018-12-19 | 2020-06-26 | 合肥铼科生物科技有限公司 | 一种含有修饰引物的核酸扩增方法和试剂盒 |
| US12595501B2 (en) | 2019-06-13 | 2026-04-07 | Global Life Sciences Solutions Usa Llc | Expression of products from nucleic acid concatemers |
| CN110295241A (zh) * | 2019-07-11 | 2019-10-01 | 深圳易致生物科技有限公司 | 用于检测尿路感染的引物组和包含该引物组的试剂盒 |
| FR3110602B1 (fr) | 2020-05-20 | 2025-03-07 | Anova Plus | Methode de detection sur le terrain de la presence et de la mutliresistance d’un bio-agresseur, notamment dezymo-septoria tritici,dans des culturescerealieres |
| CN112899346A (zh) * | 2021-01-05 | 2021-06-04 | 南京普济生物有限公司 | 一种降低pcr非特异性扩增的核苷酸及其设计方法与应用 |
| FR3129407B1 (fr) | 2021-11-25 | 2024-12-13 | Anova Plus | Methode de detection de la presence d’un pathogene et determination de ses caracteristiques en sante humaine et animale |
| CN114277103A (zh) * | 2022-01-21 | 2022-04-05 | 杭州飞时达生物科技有限公司 | 一种基于六聚体随机引物高效滚环扩增方法 |
| DE102024208236A1 (de) * | 2024-08-29 | 2026-03-05 | Robert Bosch Gesellschaft mit beschränkter Haftung | Verfahren und Vorrichtung zur Voramplifikation eines Nukleinsäuregemisches |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040086880A1 (en) * | 1999-07-20 | 2004-05-06 | Sampson Jeffrey R | Method of producing nucleic acid molecules with reduced secondary structure |
| AU2001216942A1 (en) | 2000-11-24 | 2002-06-03 | Asper Ou | Method of optimising the sequences of synthetic nucleic acids |
| US7993839B2 (en) * | 2001-01-19 | 2011-08-09 | General Electric Company | Methods and kits for reducing non-specific nucleic acid amplification |
| US20020197618A1 (en) * | 2001-01-20 | 2002-12-26 | Sampson Jeffrey R. | Synthesis and amplification of unstructured nucleic acids for rapid sequencing |
| US6617137B2 (en) | 2001-10-15 | 2003-09-09 | Molecular Staging Inc. | Method of amplifying whole genomes without subjecting the genome to denaturing conditions |
| US20030165859A1 (en) * | 2001-10-23 | 2003-09-04 | Invitrogen Corporation | Primers and methods for the detection and discrimination of nucleic acids |
| US7176002B2 (en) | 2002-05-16 | 2007-02-13 | Applera Corporation | Universal-tagged oligonucleotide primers and methods of use |
| EP1426448A1 (en) | 2002-12-03 | 2004-06-09 | bioMérieux BV | Method for lowering the effects of sequence variations in a diagnostic hybridization assay, probe for use in the assay and assay |
| US8871469B1 (en) | 2004-11-13 | 2014-10-28 | Steven Albert Benner | Self-avoiding molecular recognition systems in DNA priming |
| AU2006242387B2 (en) | 2005-04-29 | 2011-01-06 | Synthetic Genomics, Inc. | Amplification and cloning of single DNA molecules using rolling circle amplification |
| ATE502122T1 (de) | 2006-06-01 | 2011-04-15 | Trilink Biotechnologies | Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation |
| CA2691942C (en) | 2007-07-03 | 2017-12-05 | Genaphora Ltd. | Methods and kits using chimeric probes for reducing or eliminating formation of artifacts and non-specific amplification products |
| JP2010539982A (ja) | 2007-10-01 | 2010-12-24 | アプライド バイオシステムズ, エルエルシー | チェイスライゲーション配列決定法 |
| CA2777446A1 (en) | 2009-10-13 | 2011-04-21 | Syntezza Molecular Detection Israel Ltd. | Methods and compositions for amplifying target sequences from nucleic acid samples |
| US20110195457A1 (en) | 2010-02-09 | 2011-08-11 | General Electric Company | Isothermal amplification of nucleic acid using primers comprising a randomized sequence and specific primers and uses thereof |
-
2012
- 2012-04-13 US US13/446,474 patent/US9353393B2/en active Active
-
2013
- 2013-02-14 WO PCT/US2013/026136 patent/WO2013123187A1/en not_active Ceased
- 2013-02-14 JP JP2014557769A patent/JP6225123B2/ja active Active
- 2013-02-14 EP EP13749671.7A patent/EP2814976B1/en active Active
- 2013-02-14 CN CN201380009386.6A patent/CN104093850B/zh active Active
- 2013-02-14 CA CA2864676A patent/CA2864676C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013123187A1 (en) | 2013-08-22 |
| JP6225123B2 (ja) | 2017-11-01 |
| CA2864676A1 (en) | 2013-08-22 |
| EP2814976B1 (en) | 2017-10-18 |
| US20130210078A1 (en) | 2013-08-15 |
| CN104093850B (zh) | 2016-12-07 |
| EP2814976A1 (en) | 2014-12-24 |
| CN104093850A (zh) | 2014-10-08 |
| EP2814976A4 (en) | 2015-09-09 |
| US9353393B2 (en) | 2016-05-31 |
| JP2015507930A (ja) | 2015-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2864676C (en) | Methods and kits for reducing non-specific nucleic acid amplification | |
| MY164542A (en) | Method for the production of acrylic acid or its derivatives | |
| WO2011106368A3 (en) | Amplification methods to minimise sequence specific bias | |
| WO2018175258A8 (en) | Methods and compositions for preparing nucleic acid libraries | |
| MY164527A (en) | Process for production of acrylic acid or its derivatives | |
| WO2015196128A3 (en) | Alternative nucleic acid molecules and uses thereof | |
| WO2015196130A3 (en) | Alternative nucleic acid molecules and uses thereof | |
| WO2015089511A3 (en) | Modified nucleic acid molecules and uses thereof | |
| WO2016028802A8 (en) | Reusable initiators for synthesizing nucleic acids | |
| EP4269584A3 (en) | Selective antisense compounds and uses thereof | |
| WO2014014835A8 (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
| WO2012099832A3 (en) | Enzymatic ligation of nucleic acids | |
| WO2016027162A3 (en) | Methods and compositions for nucleic acid detection | |
| WO2014169079A3 (en) | Increased productivity during fermentation | |
| WO2014145128A3 (en) | Methods for amplification of nucleic acids utilizing a circularized template prepared from a target nucleic acid | |
| WO2017015433A3 (en) | Compound targeting il-23a and b-cell activating factor (baff) and uses thereof | |
| WO2017205277A3 (en) | Methods for using nucleic acid aptamers for directed templated assembly | |
| WO2014106076A3 (en) | Universal sanger sequencing from next-gen sequencing amplicons | |
| WO2015008218A3 (en) | Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant | |
| EP4296365A3 (en) | Processes for conversion of biologically derived mevalonic acid | |
| WO2012177695A3 (en) | Hybrid polymerases having the ability to produce long amplicons | |
| EP3502263A3 (en) | Method for producing objective substance | |
| WO2014057498A3 (en) | Process for the preparation of cobicistat intermediates | |
| WO2016185211A8 (en) | Process for the biological production of methacrylic acid and derivatives thereof | |
| WO2015161468A8 (en) | Methods and systems for producing isosorbide from biomass |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180213 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD Year of fee payment: 12 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250122 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250122 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250122 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD Year of fee payment: 13 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260120 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260120 |